Reduced temazepam release may lead to insufficient patient exposure, lack of hypnotic and sedative efficacy, and risk of inappropriate treatment, including dose escalation and variability of effect. Potential effects: reduced treatment efficacy, need to change therapy.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from batch 11122; patients should check the batch number on the pack and return any packs from this batch to a pharmacy; in case of doubts or treatment problems, consult a docto...
Withdrawal of batch 11122 of Signopam from the market throughout the country, prohibition of placing this batch on the market, and granting the decision immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ